Announce Date | 09/03/2025 |
EPS Normalized Actual | $0.44 (Beat by $0.023) |
EPS GAAP Actual | $0.44 (Beat by $0.023) |
Revenue Actual | $9.136B |
Revenue Surprise | Beat by $9136M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Oct 2029 | 0 | INF | 0 | 0 | 0 |
Oct 2028 | 0 | INF | 0 | 0 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ3 2025 (Jul 2025) | 0.21 | 0.21 | 9.136B | 15.61% | 9136M |
FQ2 2025 (Apr 2025) | -0.82 | -0.82 | 7.627B | 5.55% | 7627M |
FQ1 2025 (Jan 2025) | 0.45 | 0.45 | 7.854B | 13.99% | 7854M |
FQ4 2024 (Oct 2024) | 1.02 | 1.02 | 8.458B | 13.09% | 8458M |
FQ3 2024 (Jul 2024) | 0.39 | 0.39 | 7.71B | 9.18% | 7710M |
FQ1 2014 (Jan 2014) | 0 | 0 | 13.673B | 100% | 13673M |
FQ2 2014 (Apr 2014) | 0 | 0 | 13.673B | 100% | 13673M |
FQ2 2024 (Apr 2024) | 0.24 | 0.24 | 7.204B | 3.21% | 7204M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2028 (Oct 2028) | 0.85 | -- | 0.82007 | 0.87013 | 2 |
FQ3 2028 (Jul 2028) | 0.82 | -- | 0.79113 | 0.83942 | 2 |
FQ2 2028 (Apr 2028) | 0.75 | -- | 0.72359 | 0.76776 | 2 |
FQ1 2028 (Jan 2028) | 0.72 | -- | 0.69465 | 0.73705 | 2 |
FQ4 2027 (Oct 2027) | 0.6955 | -- | 0.66675 | 0.73585 | 4 |
FQ3 2027 (Jul 2027) | 0.65567 | -- | 0.62857 | 0.69371 | 4 |
FQ2 2027 (Apr 2027) | 0.56 | -- | 0.54836 | 0.57268 | 4 |
FQ1 2027 (Jan 2027) | 0.58437 | -- | 0.57357 | 0.60105 | 6 |
FQ4 2026 (Oct 2026) | 0.62636 | -- | 0.61148 | 0.6446 | 4 |
FQ3 2026 (Jul 2026) | 0.56242 | 62.66 | 0.54905 | 0.5788 | 3 |
FQ2 2026 (May 2026) | 0.54328 | 250.94 | 0.5256 | 0.56343 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2028 (Oct 2028) | 12.07B | -- | 11.74B | 12.29B | 1 |
FQ3 2028 (Jul 2028) | 11.59B | -- | 11.28B | 11.8B | 1 |
FQ2 2028 (Apr 2028) | 11B | -- | 10.7B | 11.2B | 1 |
FQ1 2028 (Jan 2028) | 13.13B | -- | 12.77B | 13.37B | 1 |
FQ4 2027 (Oct 2027) | 9.23B | -- | 8.94B | 9.64B | 6 |
FQ3 2027 (Jul 2027) | 8.98B | -- | 8.69B | 9.38B | 12 |
FQ2 2027 (Apr 2027) | 8.46B | -- | 8.32B | 8.61B | 6 |
FQ1 2027 (Jan 2027) | 8.85B | -- | 8.73B | 9.05B | 6 |
FQ4 2026 (Oct 2026) | 8.31B | -- | 8.16B | 8.49B | 6 |
FQ3 2026 (Jul 2026) | 7.88B | -15.97 | 7.73B | 8.05B | 4 |
FQ2 2026 (May 2026) | 8.06B | 5.34 | 7.86B | 8.29B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
1
EPS # of in-lines
2
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2025 (Jul 2025) | 0.21 | 0.21 | 100% | |
FQ2 2025 (Apr 2025) | -0.82 | -0.82 | 100% | |
FQ1 2025 (Jan 2025) | 0.45 | 0.45 | 100% | |
FQ4 2024 (Oct 2024) | 1.02 | 1.02 | 100% | |
FQ3 2024 (Jul 2024) | 0.39 | 0.39 | 100% | |
FQ1 2014 (Jan 2014) | 0 | 0 | NAN% | |
FQ2 2014 (Apr 2014) | 0 | 0 | NAN% | |
FQ2 2024 (Apr 2024) | 0.24 | 0.24 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2025 (Jul 2025) | $0B | $9.14B | $9136M | 100% |
FQ2 2025 (Apr 2025) | $0B | $7.63B | $7627M | 100% |
FQ1 2025 (Jan 2025) | $0B | $7.85B | $7854M | 100% |
FQ4 2024 (Oct 2024) | $0B | $8.46B | $8458M | 100% |
FQ3 2024 (Jul 2024) | $0B | $7.71B | $7710M | 100% |
FQ1 2014 (Jan 2014) | $0B | $13.67B | $13673M | 100% |
FQ2 2014 (Apr 2014) | $0B | $13.67B | $13673M | 100% |
FQ2 2024 (Apr 2024) | $0B | $7.2B | $7204M | 100% |